SKLB1002
National Institutes of Health
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Recent studies suggested that cancer stem-like cells contribute to tumor vasculogenesis by differentiating into endothelial cells…
A de novo VEGFR2-inhibited compound SKLB1002 which is independently developed in our laboratory has been described for…
Psoriasis is a common chronic inflammatory skin disease and its underlying pathogenesis is still not fully understood…
Vascular endothelial growth factor receptor (VEGFR) or vascular endothelial growth factor (VEGF) inhibitors have shown only…
Purpose: VEGF receptor 2 (VEGFR2) inhibitors, as efficient antiangiogenesis agents, have been applied in the cancer treatment…
Purpose: VEGF receptor 2 (VEGFR2) inhibitors, as efficient antiangiogenesis agents, have been applied in the cancer treatment…